Sign In
Buy LIVN
$71.33
-2.00 (-2.73%)
At Close: Jun 03, 2026
LivaNova (LIVN) Lags Q1 Earnings Estimates
11:45am, Wednesday, 29'th Apr 2020
LivaNova (LIVN) delivered earnings and revenue surprises of -2.94% and 3.25%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
LivaNova (LIVN) Lags Q1 Earnings Estimates
11:45am, Wednesday, 29'th Apr 2020
LivaNova (LIVN) delivered earnings and revenue surprises of -2.94% and 3.25%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
BRIEF-Livanova Q1 Sales From Continuing Operations $242.4 Mln
10:07am, Wednesday, 29'th Apr 2020
LivaNova PLC:
LivaNova Reports First Quarter 2020 Results
10:00am, Wednesday, 29'th Apr 2020
LivaNova PLC, a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2020.
The Global Transcatheter Pulmonary Valve Market is expected to grow from USD 41.59 Million in 2018 to USD 76.94 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.18%. Read the fu
Global Autotransfusion Devices Market (2019 to 2027) - Analysis and Forecasts
09:13am, Tuesday, 28'th Apr 2020
Dublin, April 28, 2020 -- The "Autotransfusion Devices Market to 2027 - Global Analysis and Forecasts by Type; Application; End User; and Geography" report has been added.
La canule Bi-Flow de LivaNova reoit le marquage CE pour les applications d’ECMO
05:25am, Tuesday, 28'th Apr 2020
LivaNova PLC (NASDAQ : LIVN), une société mondiale de technologie médicale et d’innovation leader sur le marché, a annoncé aujourd’hui que sa canule B
LivaNova Bi-Flow-Kanle erhlt CE-Zeichen fr ECMO-Anwendungen
05:24am, Tuesday, 28'th Apr 2020
LivaNova PLC (NASDAQ:LIVN), ein marktführendes Unternehmen für Medizintechnik und Innovationen, gab heute bekannt, dass seine Bi-Flow-Kanüle für extra
Samenvatting: LivaNova Bi-Flow-canule ontvangt CE-markering voor ECMO-toepassingen
03:22pm, Monday, 27'th Apr 2020
LivaNova PLC (NASDAQ: LIVN), een marktleider op het gebied van medische technologie en innovatie, kondigde vandaag zijn Bi-Flow Extracorporale Membran
LivaNova PLC (NASDAQ:LIVN), società leader del settore quanto a innovazione e tecnologie mediche, ha annunciato in data odierna di aver ottenuto l'aut
LivaNova Bi-Flow Cannula Receives CE Mark for ECMO Applications
01:00pm, Monday, 27'th Apr 2020
LivaNova PLC announced its Bi-Flow ECMO earned CE Mark for ECMO procedures where femoral artery cannulation can be applied.
BRIEF-Livanova PLC Says Co And Barclays Bank PLC Amended First Club Facility
12:50pm, Monday, 27'th Apr 2020
LivaNova PLC:
First Hawaiian Bank Buys 979 Shares of LivaNova PLC (NASDAQ:LIVN)
09:19am, Monday, 27'th Apr 2020
First Hawaiian Bank boosted its stake in LivaNova PLC (NASDAQ:LIVN) by 24.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutio
Pune, April 27, 2020 -- The global Transcatheter Heart Valve Replacement Market size is anticipated to reach USD 10.34 billion by 2026 on account of the increasing number of.
LivaNova PLC (NASDAQ:LIVN) Expected to Announce Quarterly Sales of $234.77 Million
05:14am, Monday, 27'th Apr 2020
Wall Street analysts expect LivaNova PLC (NASDAQ:LIVN) to announce $234.77 million in sales for the current fiscal quarter, Zacks reports. Three analysts have made estimates for LivaNova’s earnings,
